前列腺癌临床试验招募信息（全球在招）
这里汇总了全球正在招募患者的 前列腺癌（国际通用名 prostate cancer）新药临床试验，包含试验分期、招募状态、开展国家和研究团队联系方式，全部以中文呈现。数据实时来自全球最大的临床试验注册库 ClinicalTrials.gov。
正在招募的前列腺癌新药试验
Predictive and Prognostic Markers for Treatment Outcomes in Prostate Cancer Patients
不适用招募中中国台湾NCT03237026Phase 2 Randomized Trial of Flexible Dosing Schedule of 177Lu-PSMA-617 for the Treatment of Metastatic Castration-Resistant Prostate Cancer (FLEX-MRT)
II 期招募中美国NCT06216249A Single-Arm Phase II Study of Neoadjuvant Intensified Androgen Deprivation (Leuprolide and Abiraterone Acetate) in Combination With AKT Inhibition (Capivasertib) for High-Risk Localized Prostate Cancer With PTEN Loss
II 期招募中美国NCT05593497Ultralow Dose PET Imaging for PSMA Expression
II 期招募中美国NCT06904313Pacritinib in Participants With Metastatic Castrate-Resistant Prostate Cancer That Progressed on or After Prior Treatment With Androgen Receptor Signaling Inhibitors
II 期招募中美国NCT07226713Comprehensive Outcomes for After Cancer Health
不适用招募中美国NCT05349227This Study is Evaluating a New Radiation Treatment Technique for Patients Who Have Had Prostate Cancer, Undergone Surgery for Cancer, and Then Have Evidence That Their Prostate Cancer Has Returned.
II 期招募中美国NCT05946824Postop Hypofractionated Radiation Therapy and LHRH in Patients With Prostate Cancer
II 期招募中加拿大NCT04249154A Randomised Trial of Cabazitaxel, Docetaxel, Mitoxantrone or Satraplatin (CDMS) Plus Surgery for Prostate Cancer Patients
II 期 / III 期招募中中国NCT03258320Using MRI to Identify Areas to Receive Lower Doses of Radiation Treatment in Men With Prostate Cancerdose Mapping to Preserve Quality of Life
不适用招募中美国NCT06171269Training for Men Undergoing Androgen Deprivation Therapy.
不适用招募中SwedenNCT06449664Collection and Measurement of Biomarkers in Prostate Cancer Radiotherapy Patients
不适用招募中美国NCT02997709
前列腺癌试验不在中国大陆，还能参加吗？
可以尝试四条现实路径：查找国内同类试验、申请同情用药与扩展准入、赴境外研究中心入组、直接写信给申办方申请在华开展。本站提供中英文对照的咨询信模板，患者和家属填写基本情况即可生成。